443
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Ultrasound-guided microwave ablation for tertiary hyperparathyroidism in patients with renal transplantation

, , , , &
Article: 2256497 | Received 14 Apr 2023, Accepted 02 Sep 2023, Published online: 14 Sep 2023

Reference

  • Patel A, Lee CY, Sloan DA, et al. Parathyroidectomy for tertiary hyperparathyroidism: a multi-institutional analysis of outcomes. J Surg Res. 2021;258:430–434. doi: 10.1016/j.jss.2020.08.079.
  • Dulfer RR, Franssen GJH, Hesselink DA, et al. Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. Br J Surg. 2017;104(7):804–813. doi: 10.1002/bjs.10554.
  • Dream S, Kuo LE, Kuo JH, et al. The American association of endocrine surgeons guidelines for the definitive surgical management of secondary and tertiary renal hyperparathyroidism. Ann Surg. 2022;276(3):e141–e176. doi: 10.1097/SLA.0000000000005522.
  • Pihlstrøm H, Dahle DO, Mjøen G, et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation. 2015;99(2):351–359. doi: 10.1097/TP.0000000000000583.
  • Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis. Clin J Am Soc Nephrol. 2015;10(1):98–109. doi: 10.2215/CJN.12941213.
  • Copley JB, Wüthrich RP. Therapeutic management of post-kidney transplant hyperparathyroidism. Clin Transplant. 2011;25(1):24–39. doi: 10.1111/j.1399-0012.2010.01287.x.
  • Torregrosa JV, Morales E, Díaz JM, et al. Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study. Nephrology. 2014;19(2):84–93. doi: 10.1111/nep.12186.
  • Dulfer RR, Koh EY, van der Plas WY, et al. Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis. Langenbecks Arch Surg. 2019;404(1):71–79. doi: 10.1007/s00423-019-01755-4.
  • Greeviroj P, Kitrungphaiboon T, Katavetin P, et al. Cinacalcet for treatment of chronic kidney disease-mineral and bone disorder: a meta-analysis of randomized controlled trials. Nephron. 2018;139(3):197–210. doi: 10.1159/000487546.
  • van der Plas WY, Dulfer RR, Koh EY, et al. Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in The Netherlands. Langenbecks Arch Surg. 2018;403(8):999–1005. doi: 10.1007/s00423-018-1726-6.
  • Cruzado JM, Moreno P, Torregrosa JV, et al. A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol. 2016;27(8):2487–2494. doi: 10.1681/ASN.2015060622.
  • Delman AM, Turner KM, Ahmad M, et al. Surgery is underutilized in the management of tertiary hyperparathyroidism. J Surg Res. 2022;277:261–268. doi: 10.1016/j.jss.2022.04.003.
  • Finnerty BM, Chan TW, Jones G, et al. Parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery. 2019;165(1):129–134. doi: 10.1016/j.surg.2018.04.090.
  • Kandil E, Florman S, Alabbas H, et al. Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation. Am J Med Sci. 2010;339(5):420–424. doi: 10.1097/MAJ.0b013e3181d8b6ff.
  • Schwarz A, Rustien G, Merkel S, et al. Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant. 2007;22(2):584–591. doi: 10.1093/ndt/gfl583.
  • Landa MS, García SI, Liberjen L, et al. Parathyroid hormone-related protein overexpression decreases blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens. 2005;27(4):343–354. doi: 10.1081/CEH-57435.
  • Zhuo L, Zhang L, Peng LL, et al. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection. Int J Hyperthermia. 2019;36(1):29–35. doi: 10.1080/02656736.2018.1528392.
  • Wilhelm SM, Wang TS, Ruan DT, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959–968. doi: 10.1001/jamasurg.2016.2310.
  • Dream S, Chen H, Lindeman B. Tertiary hyperparathyroidism: why the delay? Ann Surg. 2021;273(3):e120–e122. doi: 10.1097/SLA.0000000000004069.
  • Isakova T, Nickolas TL, Denburg M, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKDMBD). Am J Kidney Dis. 2017;70(6):737–751. doi: 10.1053/j.ajkd.2017.07.019.
  • Diaz-Soto G, Linglart A, Sénat MV, et al. Primary hyperparathyroidism in pregnancy. Endocrine. 2013;44(3):591–597. doi: 10.1007/s12020-013-9980-4.
  • Li X, An C, Yu MG, et al. US-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: a pilot study. Int J Hyperthermia. 2019;36:322–327.
  • Hu Z, Han E, Chen W, et al. Feasibility and safety of ultrasound-guided percutaneous microwave ablation for tertiary hyperparathyroidism. Int J Hyperthermia. 2019;36:1129–1136.
  • Jeon HJ, Kim YJ, Kwon HY, et al. Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int. 2012;25(12):1248–1256. doi: 10.1111/j.1432-2277.2012.01564.x.
  • Schlosser K, Endres N, Celik I, et al. Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters!. World J Surg. 2007;31(10):1947–1953. doi: 10.1007/s00268-007-9187-z.
  • Evenepoel P, Claes K, Kuypers D, et al. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single Centre study. Nephrol Dial Transplant. 2005;20(8):1714–1720. doi: 10.1093/ndt/gfh892.